The team of our chief scientific advisor has developed an intermediate mesoderm that faithfully reproduces the developmental process from pluripotent stem cells and a highly efficient method for inducing differentiation of intermediate mesoderm into NPCs.

They also showed that cell therapy with NPCs is effective in several mouse models of renal disease.
Currently, a patent is pending for the differentiation induction method. According to the opinion of an international patent research organization, there is novelty and inventive step in the method of producing NPCs from iPS cells.